These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 34774918)

  • 1. pH-Dependent Phase Behavior and Stability of Cationic Lipid-mRNA Nanoparticles.
    Larson NR; Hu G; Wei Y; Tuesca AD; Forrest ML; Middaugh CR
    J Pharm Sci; 2022 Mar; 111(3):690-698. PubMed ID: 34774918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-dependent structural transitions in cationic ionizable lipid mesophases are critical for lipid nanoparticle function.
    Philipp J; Dabkowska A; Reiser A; Frank K; Krzysztoń R; Brummer C; Nickel B; Blanchet CE; Sudarsan A; Ibrahim M; Johansson S; Skantze P; Skantze U; Östman S; Johansson M; Henderson N; Elvevold K; Smedsrød B; Schwierz N; Lindfors L; Rädler JO
    Proc Natl Acad Sci U S A; 2023 Dec; 120(50):e2310491120. PubMed ID: 38055742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid crystalline inverted lipid phases encapsulating siRNA enhance lipid nanoparticle mediated transfection.
    Pattipeiluhu R; Zeng Y; Hendrix MMRM; Voets IK; Kros A; Sharp TH
    Nat Commun; 2024 Feb; 15(1):1303. PubMed ID: 38347001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions.
    Reinhart AG; Osterwald A; Ringler P; Leiser Y; Lauer ME; Martin RE; Ullmer C; Schumacher F; Korn C; Keller M
    Mol Pharm; 2023 Dec; 20(12):6492-6503. PubMed ID: 37975733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Payload distribution and capacity of mRNA lipid nanoparticles.
    Li S; Hu Y; Li A; Lin J; Hsieh K; Schneiderman Z; Zhang P; Zhu Y; Qiu C; Kokkoli E; Wang TH; Mao HQ
    Nat Commun; 2022 Sep; 13(1):5561. PubMed ID: 36151112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrophobic scaffolds of pH-sensitive cationic lipids contribute to miscibility with phospholipids and improve the efficiency of delivering short interfering RNA by small-sized lipid nanoparticles.
    Sato Y; Okabe N; Note Y; Hashiba K; Maeki M; Tokeshi M; Harashima H
    Acta Biomater; 2020 Jan; 102():341-350. PubMed ID: 31733331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction Kinetics of Individual mRNA-Containing Lipid Nanoparticles with an Endosomal Membrane Mimic: Dependence on pH, Protein Corona Formation, and Lipoprotein Depletion.
    Aliakbarinodehi N; Gallud A; Mapar M; Wesén E; Heydari S; Jing Y; Emilsson G; Liu K; Sabirsh A; Zhdanov VP; Lindfors L; Esbjörner EK; Höök F
    ACS Nano; 2022 Dec; 16(12):20163-20173. PubMed ID: 36511601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.
    Sato Y; Hashiba K; Sasaki K; Maeki M; Tokeshi M; Harashima H
    J Control Release; 2019 Feb; 295():140-152. PubMed ID: 30610950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles.
    Yanez Arteta M; Kjellman T; Bartesaghi S; Wallin S; Wu X; Kvist AJ; Dabkowska A; Székely N; Radulescu A; Bergenholtz J; Lindfors L
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3351-E3360. PubMed ID: 29588418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
    Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
    AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of lipid nanoparticle surface structure in mRNA vaccines.
    Wang MM; Wappelhorst CN; Jensen EL; Chi YT; Rouse JC; Zou Q
    Sci Rep; 2023 Oct; 13(1):16744. PubMed ID: 37798336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preparation method for mRNA-LNPs with improved properties.
    Geng C; Zhou K; Yan Y; Li C; Ni B; Liu J; Wang Y; Zhang X; Wang D; Lv L; Zhou Y; Feng A; Wang Y; Li C
    J Control Release; 2023 Dec; 364():632-643. PubMed ID: 37956926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leveraging Biological Buffers for Efficient Messenger RNA Delivery via Lipid Nanoparticles.
    Henderson MI; Eygeris Y; Jozic A; Herrera M; Sahay G
    Mol Pharm; 2022 Nov; 19(11):4275-4285. PubMed ID: 36129254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and lyophilization of mRNA-encapsulating lipid nanoparticles.
    Wang T; Yu T; Li W; Liu Q; Sung TC; Higuchi A
    Int J Pharm; 2024 Sep; 662():124514. PubMed ID: 39067550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration.
    Carrasco MJ; Alishetty S; Alameh MG; Said H; Wright L; Paige M; Soliman O; Weissman D; Cleveland TE; Grishaev A; Buschmann MD
    Commun Biol; 2021 Aug; 4(1):956. PubMed ID: 34381159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Dynamics Simulation of Lipid Nanoparticles Encapsulating mRNA.
    Zhang Z; Cheng D; Luo W; Hu D; Yang T; Hu K; Liang L; Liu W; Hu J
    Molecules; 2024 Sep; 29(18):. PubMed ID: 39339404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating Lipid Nanoparticles with Histidinamide-Conjugated Cholesterol for Improved Intracellular Delivery of mRNA.
    Jung O; Jung HY; Thuy LT; Choi M; Kim S; Jeon HG; Yang J; Kim SM; Kim TD; Lee E; Kim Y; Choi JS
    Adv Healthc Mater; 2024 Jun; 13(14):e2303857. PubMed ID: 38344923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid Nanoparticle and Liposome Reference Materials: Assessment of Size Homogeneity and Long-Term -70 °C and 4 °C Storage Stability.
    Jakubek ZJ; Chen S; Zaifman J; Tam YYC; Zou S
    Langmuir; 2023 Feb; 39(7):2509-2519. PubMed ID: 36748988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.